Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
Orsiro randomized trials evaluating the biodegradable polymer sirolimus-eluting stent (BP-SES; 60 and 80 pM stent strut thickness to diameter ≤3 and> 3 mm, respectively) did not stratify according to size of the ship and failed to determine the impact of ultrathin- strut thickness the long-term clinical outcomes compared with a durable polymer everolimus-eluting stent (DP-EES).
We are trying to assess the long-term effects of ultrathin-strut (60 m) BP-SES compared to thin-strut (81 m) DP-ees on long-term outcomes in patients undergoing percutaneous coronary revascularization for small boats disease.In subgroup analysis of a randomized, multicenter, noninferiority trial Bioscience, patients with stable coronary artery disease or acute coronary syndrome were randomly assigned to treatment with BP-SES or DP-EES grouped by the size of the vessel (≤3 mm vs> 3 mm) as a replacement for comparing patients treated with ultrathin-thin-strut strut vs. drug-eluting stent. The primary endpoint is target lesion failure, a composite of cardiac death, target vessel myocardial infarction and clinically indicated target lesion revascularization, within 5 years.
RESULTS Among the 2109 patients, 1234 (59%) treated for small vessel disease. At 5 years, the target lesion failure occurred in 124 patients (cumulative incidence, 22.3%) were treated with ultrathin-strut BP-SES and 109 patients (18.3%) were treated with a thin-strut DP-EES (rate ratio, 1 , 22; 95% CI, 0.94 to 1.58; P = 0.13).
The cumulative incidence of cardiac death, target vessel myocardial infarction and clinically indicated target lesion revascularization and definite stent thrombosis at 5 years was similar in patients treated with ultrathin-strut BP-SES and thin-strut DP-EES. After adjustment for potential confounders, there was no significant interaction between treatment effect size of the ship and BP-SES compared to DP-EES. We found no significant differences in clinical outcomes throughout the 5 years between patients with small vessel disease treated with ultrathin-strut BP-SES compared to thin-strut DP-EES.URL
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
ALFA-tag is a very versatile tool for nanobody-based bioscience applications.
Special epitope tags are widely used to detect, manipulate or purify proteins, but often they have limited flexibility. Here, we introduce ALFA-tags, epitope tags are designed rationally serves a very broad spectrum of applications in life sciences while outperformed tag was established as ha-, FLAG®- or myc-tag. ALFA-forms of α-helix tag is small and stable despite its position in the target protein functional in prokaryotic and eukaryotic hosts.
We characterize nanobody (NbALFA) binding protein ALFA-tag of the original specimen or stick with low picomolar affinity. It is suitable for super-resolution microscopy, immunoprecipitations and Western blotting, and also allows the in vivo detection of protein. We were shown a complex crystal structure that allows us to design a mutant nanobody (NbALFAPE) which allows the efficient purification step original ALFA-tagged proteins, complexes and even whole living cells using a peptide elution under physiological conditions.
Recent developments in genotyping technology coupled with the growing desire to characterize genomic variation in populations of Anopheles an opportunity to develop more effective strategies for the genotypes of high-throughput screening. A major obstacle of this objective is the extraction of nucleic acids.
Description: The anti-IgY beads were made by cross-linking of bovine IgG anti-IgY antibodies to Protein A/G agarose beads. IgY is the original designation of chicken IgG like immunoglobulin.
Description: The histone deacetylase (HDAC) family contains multiple members which are divided into four classes. Class I of the HDAC family comprises four members, HDAC1, 2, 3, and 8, each of which contains a deacetylase domain and exhibits a different, individual substrate specificity and function in vivo (1). HDAC1 is responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (1,2). HDAC1 gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (3,4).
Description: The histone deacetylase (HDAC) family contains multiple members which are divided into four classes. Class I of the HDAC family comprises four members, HDAC1, 2, 3, and 8, each of which contains a deacetylase domain and exhibits a different, individual substrate specificity and function in vivo (1). HDAC1 is responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4) (1,2). HDAC1 gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events (3,4).
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC, IF
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:1000, IHC:1:10-1:50
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:200-1:1000, IHC:1:25-1:100
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF, ChIP; Recommended dilution: IHC:1:20-1:200, IF:1:100-1:500
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/5000
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, IF, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.IF:1/200-1/1000.ELISA:1/10000
Description: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Component a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development.
Description: Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Component a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development.
Description: HDAC1 is responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation. [UniProt]
Description: HDAC1 is responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Deacetylates SP proteins, SP1 and SP3, and regulates their function. Component of the BRG1-RB1-HDAC1 complex, which negatively regulates the CREST-mediated transcription in resting neurons. Upon calcium stimulation, HDAC1 is released from the complex and CREBBP is recruited, which facilitates transcriptional activation. Deacetylates TSHZ3 and regulates its transcriptional repressor activity. Deacetylates 'Lys-310' in RELA and thereby inhibits the transcriptional activity of NF-kappa-B. Deacetylates NR1D2 and abrogates the effect of KAT5-mediated relieving of NR1D2 transcription repression activity. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Involved in CIART-mediated transcriptional repression of the circadian transcriptional activator: CLOCK-ARNTL/BMAL1 heterodimer. Required for the transcriptional repression of circadian target genes, such as PER1, mediated by the large PER complex or CRY1 through histone deacetylation. [UniProt]
Description: Histone acetylation and deacetylation, catalyzed by multisubunit complexes, play a key role in the regulation of eukaryotic gene expression. HDAC1 belongs to the histone deacetylase/acuc/apha family and is a component of the histone deacetylase complex. It also interacts with retinoblastoma tumor-suppressor protein and this complex is a key element in the control of cell proliferation and differentiation. Together with metastasis-associated protein-2, it deacetylates p53 and modulates its effect on cell growth and apoptosis.
Description: Histone acetylation and deacetylation, catalyzed by multisubunit complexes, play a key role in the regulation of eukaryotic gene expression. HDAC1 belongs to the histone deacetylase/acuc/apha family and is a component of the histone deacetylase complex. It also interacts with retinoblastoma tumor-suppressor protein and this complex is a key element in the control of cell proliferation and differentiation. Together with metastasis-associated protein-2, it deacetylates p53 and modulates its effect on cell growth and apoptosis.
Description: Histone acetylation and deacetylation, catalyzed by multisubunit complexes, play a key role in the regulation of eukaryotic gene expression. HDAC1 belongs to the histone deacetylase/acuc/apha family and is a component of the histone deacetylase complex.
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HDAC1 . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HDAC1 . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HDAC1 . This antibody is tested and proven to work in the following applications:
Description: A polyclonal antibody for detection of HDAC1 from Human, Mouse, Rat. This HDAC1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human HDAC1 around the non-phosphorylation site of S421
Description: A polyclonal antibody for detection of HDAC1 from Human, Mouse, Rat. This HDAC1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human HDAC1 around the non-phosphorylation site of S421
Description: A polyclonal antibody for detection of HDAC1 from Human, Mouse, Rat. This HDAC1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from human HDAC1 around the non-phosphorylation site of S421
Description: A polyclonal antibody for detection of HDAC1 from Human, Mouse, Rat. This HDAC1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human HDAC1
Description: A polyclonal antibody for detection of HDAC1 from Human, Mouse, Rat. This HDAC1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human HDAC1
Description: A polyclonal antibody for detection of HDAC1 from Human, Mouse, Rat. This HDAC1 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human HDAC1
Description: The Kinetic HDAC1 Assay Kit is a complete assay system designed to_x000D_measure histone deacetylase 1 (HDAC1) activity kinetically for screening and profiling_x000D_applications. It comes in a convenient 96-well format, with all the reagents necessary for_x000D_100 fluorescent HDAC1 activity measurements. In addition, the kit includes purified_x000D_HDAC1 enzyme and a potent HDAC inhibitor, SAHA, for use as a positive and negative_x000D_control. The Kinetic HDAC1 Assay Kit is based on a unique fluorogenic substrate and_x000D_developer combination. This assay method eliminates dealing with the radioactivity,_x000D_extraction, and chromatography aspects of traditional assays. Using this kit, only one_x000D_simple step for setting up the HDAC1 reaction on a microtiter plate is needed and then_x000D_the HDAC1 activity level can be measured kinetically using a fluorescence reader.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is unconjugated.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 390.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 488.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 565.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 594.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 633.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 655.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 680.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to ATTO 700.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Alkaline Phosphatase.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to APC .
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to APC/Cy7.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Biotin.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Dylight 350.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Dylight 405.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Dylight 488.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Dylight 594.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Dylight 633.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to FITC.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to HRP.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to PE/ATTO 594.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to PerCP.
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to RPE .
Description: A polyclonal antibody for HDAC1 from Human | Mouse | Rat. The antibody is produced in rabbit after immunization with Human Synthesized peptide derived from human HDAC1.. The Antibody is tested and validated for WB, IHC, ICC/IF, ELISA assays with the following recommended dilutions: WB (1:1000), IHC (1:100), ICC/IF (1:500), ELISA (1:10000). This HDAC1 antibody is conjugated to Streptavidin.
Description: The Fluorogenic HDAC1 Assay Kit is a complete assay system_x000D_designed to measure histone deacetylase 1 (HDAC1) activity for screening and profiling_x000D_applications. It comes in a convenient 96-well format, with all the reagents necessary for_x000D_100 fluorescent HDAC1 activity measurements. In addition, the kit includes purified_x000D_HDAC1 enzyme and a potent HDAC inhibitor, Trichostatin A, for use as a positive and_x000D_negative control. The Fluorogenic HDAC1 Assay Kit is based on a unique fluorogenic_x000D_substrate and developer combination. This assay method eliminates dealing with the_x000D_radioactivity, extraction, and chromatography aspects of traditional assays. Using this kit,_x000D_only two simple steps on a microtiter plate are needed to analyze the HDAC activity_x000D_level. First, the HDAC fluorometric substrate, containing an acetylated lysine side chain,_x000D_is incubated with purified HDAC1. The deacetylation sensitizes the substrate so_x000D_subsequent treatment with the Lysine Developer produces a fluorophore that can then_x000D_be measured using a fluorescence reader._x000D_
Description: A polyclonal antibody against HDAC1. Recognizes HDAC1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA
Here, we test the feasibility of using an integral part of the foot of mosquitoes as the source of template DNA for whole genome amplification (WGA) by primer-extension preamplification. We use Agena Biosciences MassARRAY (®) platform (formerly Sequenom) to genotype SNPs 78 to 265 feet WGA samples.
Beau
